AstraZeneca Investors Press Exec-Comp Chair to Tie Pay to Pfizer Bid
To follow through on calls to link AstraZeneca executive pay to the value of Pfizer's ($PFE) rejected buyout offer. Last month, AstraZeneca rebuffed the U.S. drug giant's £55 per share bid, saying shareholders would be better served if the company pursued its ...
Login to comment.